Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telavancin vs Vancomycin for Hospital-Acquired Pneumonia (ATTAIN 1)
NCT00107952Phase 3Completed
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Feb 2005
- Primary completion
- Jul 2007
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of telavancin in hospital-acquired pneumonia (HAP), sponsored by Cumberland Pharmaceuticals. Started Feb 2005; status: completed.
02
Drugs
telavancin
03
Conditions
hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on NCT00107952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107952.